Neoantigen Targeted Therapies Market 2028 By Therapy Type, End User and Geography | The Insight Partners

report image

Neoantigen Targeted Therapies Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Therapy Type (Combination Therapy and Monotherapy); End User (Hospitals & Clinics, Medical Research Institutions and Other End Users) and Geography

Report Code: TIPRE00008685 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Neoantigen targeted therapies are being used widely for the treatment of cancerous cells. Neoantigens are tumor-specific antigens which formed due to the instability of tumor cells. Neoantigens are highly immunogenic; hence they are not expressed in healthy tissues. The concept of using identified neoantigens as vaccines to efficiently stimulate patients' autoimmune system and generate anti-tumor response has gained recognition.


The neoantigen targeted therapies market is anticipated to grow in the forecast, owing to an increasing prevalence of cancer, coupled with the availability of different treatment options. Also, the rise in R&D expenditures made by the manufacturers for the introduction of new drugs is anticipated to offer significant growth opportunities in the market during the forecast period.


The "Neoantigen Targeted Therapies Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a particular focus on the global market trend analysis. The report aims to provide an overview of the neoantigen targeted therapies market with detailed market segmentation by therapy type, end user, and geography. The neoantigen targeted therapies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading neoantigen targeted therapies market players and offers key trends and opportunities in the market.


The neoantigen targeted therapies market is segmented based on therapy type and end user. Based on the therapy type, the market is segmented as combination therapy and monotherapy. Based on end user, the market is classified as hospitals & clinics, medical research institutions, and other end users.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the neoantigen targeted therapies market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neoantigen targeted therapies market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting neoantigen targeted therapies market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the neoantigen targeted therapies market in these regions.

Get more information on this report :


The report covers key developments in the neoantigen targeted therapies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from neoantigen targeted therapies market are anticipated to have lucrative growth opportunities in the future with the rising demand for neoantigen targeted therapies market in the global market. Below mentioned is the list of few companies engaged in the neoantigen targeted therapies market.

The report also includes the profiles of key neoantigen targeted therapies market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Achilles Therapeutics
- Advaxis, Inc.
- Frame Cancer Therapeutics
- Genocea Biosciences, Inc.
- Gradalis, Inc.
- Gritstone Oncology
- Immunicum AB
- Iovance Biotherapeutics, Inc.
- Medigene
- Neon Therapeutics

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Achilles Therapeutics
2. Advaxis, Inc.
3. Frame Cancer Therapeutics
4. Genocea Biosciences, Inc.
5. Gradalis, Inc.
6. Gritstone Oncology
7. Immunicum AB
8. Iovance Biotherapeutics, Inc.
9. Medigene
10. Neon Therapeutics
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount